SynthesisPLoS medicine2020

Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression.

Giovanni Musso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.